Skip to main content

Closed

CRNX: Crinetics Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-3020.3%

ROIC-40.8%

Financially safe

Stretched

Debt / equity0.04×

Interest coverage0.0×

Current ratio18.60×

Crinetics Pharmaceuticals, Inc.

CRNXNASDAQ Global Select·USD·Closed

Crinetics Pharmaceuticals, Inc.

CRNXNASDAQ·USD·Closed

$83.52

−0.13%

$83.52

−$0.11 (0.13%)

52W Range

99thpctl

Volume

0.50×avg

Mkt Cap

8.84BUSD

P/E

-16.2TTM

Div Yield

–ann

52W Range

99thpctl

Volume

0.50×avg

Market Cap

8.84BUSD

P/E Ratio

-16.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings